Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Precision Medicine in Non Communicable Diseases Publisher



Hasanzad M1, 2 ; Sarhangi N2 ; Meybodi HRA2 ; Nikfar S2, 3 ; Khatami F4 ; Larijani B2, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Molecular and Cellular Medicine Published:2019


Abstract

Non-communicable diseases (NCDs) are the leading cause of death and disease burden globally, cardiovascular diseases (CVDs) account for the major part of death related to NCDs followed by different types of cancer,chronic obstructive pulmonary disease (COPD), and diabetes. As the World Health Organization (WHO) andthe United Nations have announced a 25% reduction in mortality of NCDs by 2025, different communities needto adopt preventive strategies for achieving this goal. Personalized medicine approach as a predictive andpreventive strategy aims for a better therapeutic goal to the patients to maximize benefits and reduce harms. Theclinical benefits of this approach are already realized in cancer targeted therapy, and its impact on otherconditions needs more studies in different societies. In this review, we essentially describe the concept ofpersonalized (or precision) medicine in association with NCDs and the future of precision medicine inprediction, prevention, and personalized treatment © 2019, International Journal of Molecular and Cellular Medicine. All Rights Reserved.
Related Docs
View other Related Docs
1. Precision Medicine in Endocrinology Practice, Precision Medicine in Clinical Practice (2022)
2. Investigating the Role of Circulating Tumor Cells in Gastric Cancer: A Comprehensive Systematic Review and Meta-Analysis, Clinical and Experimental Medicine (2024)
3. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
4. A Narrative Review of Current Trends in Liraglutide: Insights Into the Unmet Needs in Management of Type 2 Diabetes and Obesity, Journal of Diabetes and Metabolic Disorders (2020)
5. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
6. Tumor Immunology, Clinical Immunology (2022)
7. Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study From Iran, Middle East Journal of Digestive Diseases (2021)
8. A 10-Year Isfahan Cohort on Cardiovascular Disease As a Master Plan for a Multi-Generation Non-Communicable Disease Longitudinal Study: Methodology and Challenges, Journal of Human Hypertension (2019)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (12)
Farshad Farzadfar (10)
Other Related Docs
9. Microrna-155 and Its Exosomal Form: Small Pieces in the Gastrointestinal Cancers Puzzle, Cell Biology and Toxicology (2024)
10. Pharmacogenomic Approach in Type 2 Diabetes Treatment, Koomesh (2022)
11. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
12. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
13. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
14. Role of Btla/Hvem Network in Development of Gastric Cancer, Human Immunology (2022)
15. Protocol Design for Large-Scale Cross-Sectional Studies of Surveillance of Risk Factors of Non-Communicable Diseases in Iran: Steps 2016, Archives of Iranian Medicine (2017)
16. Micrornas As Biomarkers for Early Diagnosis, Targeting and Prognosis of Prostate Cancer, Pathology Research and Practice (2023)
17. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
18. Naringenin and Cryptotanshinone Shift The Immune Response Towards Th1 and Modulate T Regulatory Cells Via Jak2/Stat3 Pathway in Breast Cancer, BMC Complementary Medicine and Therapies (2022)
19. Prediction of Anti-Cd25 and 5-Fu Treatments Efficacy for Pancreatic Cancer Using a Mathematical Model, BMC Cancer (2021)
20. A Meta-Analysis on Human Papillomavirus Type Distribution Among Women With Cervical Neoplasia in the Who Eastern Mediterranean Region, Intervirology (2019)
21. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)
22. Iran in Transition, The Lancet (2019)
23. Reducing Sugar, Fat, and Salt for Prevention and Control of Noncommunicable Diseases (Ncds) As an Adopted Health Policy in Iran, Medical Journal of the Islamic Republic of Iran (2020)
24. The Role of Inflammatory Mirna–Mrna Interactions in Pbmcs of Colorectal Cancer and Obesity Patients, Immunity# Inflammation and Disease (2022)
25. Evaluation of Targetable Biomarkers for Chimeric Antigen Receptor T-Cell (Car-T) in the Treatment of Pancreatic Cancer: A Systematic Review and Meta-Analysis of Preclinical Studies : Pancreatic Cancer Is One of the Lethal Malignant Tumours in the World. in This Study, We Investigated the Car T-Cell Therapy of Pancreatic Cancer, International Reviews of Immunology (2020)
26. A Comprehensive Review About the Utilization of Immune Checkpoint Inhibitors and Combination Therapy in Hepatocellular Carcinoma: An Updated Review, Cancer Cell International (2022)
27. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
28. Scientometric Study on Non-Communicable Diseases in Iran: A Review Article, Iranian Journal of Public Health (2018)
29. Recent Advances in Immune Checkpoint Therapy in Non-Small Cell Lung Cancer and Opportunities for Nanoparticle-Based Therapy, European Journal of Pharmacology (2021)
30. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope, Acta Medica Iranica (2017)
31. Pancreatic Cancer in Iran - Result of the Iranian National Cancer Registry Program, Asian Pacific Journal of Cancer Prevention (2022)
32. Critical Involvement of Circular Rnas in Virus-Associated Cancers, Genes and Diseases (2023)
33. National Action Plan for Non-Communicable Diseases Prevention and Control in Iran; a Response to Emerging Epidemic, Journal of Diabetes and Metabolic Disorders (2017)
34. The First Nationally and Sub-Nationally Representative Non-Communicable Diseases Cohort Study in Iran: Iran Cohort Study (Ics) Protocol, Journal of Diabetes and Metabolic Disorders (2023)
35. Analysis of the Results of Cardiovascular Disease Risk Assessment Program, Journal of Babol University of Medical Sciences (2021)
36. Systematic Review and Meta-Analysis of Human Papillomavirus Prevalence and Types Among Women With Normal Cervical Cytology in the Eastern Mediterranean Region, Future Virology (2019)
37. The Effect of Metformin on Biomarkers Associated With Breast Cancer Outcomes: A Systematic Review, Meta-Analysis, and Dose–Response of Randomized Clinical Trials, Clinical and Translational Oncology (2020)
38. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
39. Exploring the Potential of Machine Learning in Gastric Cancer: Prognostic Biomarkers, Subtyping, and Stratification, BMC Cancer (2025)
40. The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the Globocan 2012 to 2018 Estimates, Value in Health Regional Issues (2022)
41. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
42. Immunotherapy of Gastric and Esophageal Cancers, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
43. Global, Regional, and National Burden and Quality of Care Index (Qci) of Thyroid Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990–2017, Cancer Medicine (2021)